{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:22:07Z","timestamp":1791645727913,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jaip.2017.07.032","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T02:01:30Z","timestamp":1505959290000},"page":"907-915.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies"],"prefix":"10.1016","volume":"6","author":[{"given":"Samatha","family":"Sonnappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"McQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirkje S.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gouder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Pizzichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Phipatanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Dandurand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8795-5528","authenticated-orcid":false,"given":"Alan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-9516","authenticated-orcid":false,"given":"Willem M.C.","family":"van Aalderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar S.","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.07.032_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/dtb.2008.05.0013","article-title":"Switching to CFC-free beclometasone for asthma","volume":"46","year":"2008","journal-title":"Drug Ther Bull"},{"key":"10.1016\/j.jaip.2017.07.032_bib2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1067\/mai.2000.111582","article-title":"Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma","volume":"106","author":"Vanden Burgt","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/jam.2005.18.379","article-title":"Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler","volume":"18","author":"Leach","year":"2005","journal-title":"J\u00a0Aerosol Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.98.12061346","article-title":"Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone","volume":"12","author":"Leach","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.07.032_bib5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.coph.2010.06.001","article-title":"New asthma drugs: small molecule inhaled corticosteroids","volume":"10","author":"Gentile","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jaip.2017.07.032_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14656566.9.3.479","article-title":"Inhaled beclometasone dipropionate\/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives","volume":"9","author":"Fabbri","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaip.2017.07.032_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/ajrccm.156.3.9608058","article-title":"Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity","volume":"156","author":"Lawrence","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1183\/09031936.97.10020292","article-title":"The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics","volume":"10","author":"Carroll","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.07.032_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1164\/ajrccm.158.2.9705036","article-title":"Inflammatory cell distribution within and along asthmatic airways","volume":"158","author":"Haley","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1378\/chest.10-1210","article-title":"Small airway disease in asthma and COPD: clinical implications","volume":"139","author":"van den Berge","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.07.032_bib11","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1164\/ajrccm.157.5.rsaa-8","article-title":"Effect of drugs on small airways","volume":"157","author":"Woolcock","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib12","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jaci.2009.09.050","article-title":"Particle size of inhaled corticosteroids: does it matter?","volume":"124","author":"Leach","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1378\/chest.122.2.510","article-title":"Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers","volume":"122","author":"Leach","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.07.032_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.rmed.2005.09.027","article-title":"High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma","volume":"100","author":"Newman","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pupt.2009.01.005","article-title":"Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry","volume":"22","author":"Yamaguchi","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.07.032_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2011.11.017","article-title":"The role of the small airways in the clinical expression of asthma in adults","volume":"129","author":"Farah","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jaci.2012.09.022","article-title":"Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children","volume":"131","author":"Shi","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0954-6111(98)90214-1","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose","volume":"92","author":"Davies","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.115.2.343","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma","volume":"115","author":"Gross","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.07.032_bib20","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.rmed.2007.05.006","article-title":"Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma","volume":"101","author":"Vermeulen","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-3038.2007.00538.x","article-title":"Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma","volume":"18","author":"von","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0091-6749(99)70016-3","article-title":"Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant","volume":"104","author":"Busse","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1081-1206(10)62905-5","article-title":"Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol","volume":"86","author":"Fireman","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib24","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1378\/chest.121.6.1824","volume":"121","author":"Juniper","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.07.032_bib25","first-page":"123","article-title":"Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months","volume":"11","author":"Boulet","year":"2004","journal-title":"Can Respir J"},{"key":"10.1016\/j.jaip.2017.07.032_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaci.2010.06.040","article-title":"Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study","volume":"126","author":"Price","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1365-2222.2011.03820.x","article-title":"Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study","volume":"41","author":"Barnes","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.07.032_bib28","doi-asserted-by":"crossref","first-page":"14081","DOI":"10.1038\/npjpcrm.2014.81","article-title":"Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study","volume":"24","author":"Martin","year":"2014","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib29","first-page":"1163","article-title":"Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD","volume":"9","author":"Postma","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2017.07.032_bib30","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.201411-2116LE","article-title":"Differential effects of inhaled corticosteroids in smokers\/ex-smokers and nonsmokers with asthma","volume":"191","author":"Roche","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12890-016-0234-0","article-title":"Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands","volume":"16","author":"van der Molen","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.rmed.2011.10.001","article-title":"Real-life prospective study on asthma control in Italy: cross-sectional phase results","volume":"106","author":"Allegra","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2006.03.004","article-title":"Limited search strategies were effective in finding relevant nonrandomized studies","volume":"59","author":"Furlan","year":"2006","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2017.07.032_bib34","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2017.07.032_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2288-10-11","article-title":"Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials","volume":"10","author":"Rios","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jaip.2017.07.032_bib36","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1513\/AnnalsATS.201309-300RM","article-title":"Quality standards for real-world research: focus on observational database studies of comparative effectiveness","volume":"11","author":"Roche","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2017.07.032_bib37","series-title":"Stata Statistical Software","year":"2015"},{"key":"10.1016\/j.jaip.2017.07.032_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaip.2017.07.032_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4104\/pcrj.2013.00088","article-title":"Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients","volume":"22","author":"Price","year":"2013","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2017.07.032_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2013.02.008","article-title":"Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone","volume":"132","author":"Colice","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaip.2015.04.012","article-title":"Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma","volume":"3","author":"van Aalderen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.07.032_bib42","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.rmed.2013.03.009","article-title":"Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma","volume":"107","author":"Price","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jaip.2017.07.032_bib44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jaip.2017.07.032_bib45","first-page":"89","article-title":"A\u00a0nonparametric \u201ctrim and fill\u201d method of accounting for publication bias in meta-analysis","volume":"95","author":"Duval","year":"2000","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jaip.2017.07.032_bib46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1183\/09059180.00008111","article-title":"Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years","volume":"21","author":"Demoly","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2017.07.032_bib47","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1136\/thx.2008.097741","article-title":"British guideline on the management of asthma","volume":"63","author":"British Thoracic Society, Scottish Intercollegiate Guidelines Network","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.07.032_bib48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2008.09.035","article-title":"High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study","volume":"123","author":"Thomas","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.anai.2012.06.022","article-title":"Are we overlooking persistent small airways dysfunction in community-managed asthma?","volume":"109","author":"Anderson","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000339550","article-title":"Pathogenesis of small airways in asthma","volume":"84","author":"Hamid","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.jaip.2017.07.032_bib52","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.rmed.2013.08.009","article-title":"Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction","volume":"107","author":"Perez","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib53","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.jaci.2013.03.009","article-title":"Alveolar nitric oxide and asthma control in mild untreated asthma","volume":"131","author":"Scichilone","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.07.032_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MCP.0000000000000115","article-title":"Small-airway disease in asthma: pharmacological considerations","volume":"21","author":"Usmani","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1465-9921-5-17","article-title":"Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review","volume":"5","author":"Kankaanranta","year":"2004","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2017.07.032_bib56","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00074905","article-title":"Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma","volume":"28","author":"Derendorf","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.07.032_bib57","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pupt.2005.01.004","article-title":"Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients","volume":"18","author":"Derom","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.07.032_bib58","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0091270009354994","article-title":"Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma","volume":"50","author":"Xu","year":"2010","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jaip.2017.07.032_bib59","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1368-5031.2004.00274.x","article-title":"The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 2): clinical experience in children","volume":"58","author":"van Schayck","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaip.2017.07.032_bib60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00128072-200305070-00005","article-title":"Safety of the newer inhaled corticosteroids in childhood asthma","volume":"5","author":"Randell","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaip.2017.07.032_bib61","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/S2213-2600(13)70199-1","article-title":"Integrating real-life studies in the global therapeutic research framework","volume":"1","author":"Roche","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rmed.2004.03.026","article-title":"How representative are clinical study patients with asthma or COPD for a larger \u201creal life\u201d population of patients with obstructive lung disease?","volume":"99","author":"Herland","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.07.032_bib63","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11882-011-0222-7","article-title":"Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness","volume":"11","author":"Price","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2017.07.032_bib64","unstructured":"Food and Drug Administration. Using real-world evidence to accelerate safe and effective cures. Available from: http:\/\/cdn.bipartisanpolicy.org\/wp-content\/uploads\/2016\/06\/BPC-Health-Innovation-Safe-Effective-Cures.pdf. Accessed August 11, 2016."},{"key":"10.1016\/j.jaip.2017.07.032_bib65","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","year":"2011"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817305573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817305573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:17:09Z","timestamp":1761974229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817305573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2213219817305573"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.07.032","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}